Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 770 USD -0.15% Market Closed
Updated: May 19, 2024

Eli Lilly and Co
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eli Lilly and Co
Selling, General & Administrative Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Selling, General & Administrative
-$7.6B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-1%
Johnson & Johnson
NYSE:JNJ
Selling, General & Administrative
-$21.9B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
Bristol-Myers Squibb Co
NYSE:BMY
Selling, General & Administrative
-$7.9B
CAGR 3-Years
-1%
CAGR 5-Years
-12%
CAGR 10-Years
-5%
Pfizer Inc
NYSE:PFE
Selling, General & Administrative
-$14.5B
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Selling, General & Administrative
-$10.4B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Zoetis Inc
NYSE:ZTS
Selling, General & Administrative
-$2.2B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-3%

See Also

What is Eli Lilly and Co's Selling, General & Administrative?
Selling, General & Administrative
-7.6B USD

Based on the financial report for Mar 31, 2024, Eli Lilly and Co's Selling, General & Administrative amounts to -7.6B USD.

What is Eli Lilly and Co's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-1%

Over the last year, the Selling, General & Administrative growth was -15%. The average annual Selling, General & Administrative growth rates for Eli Lilly and Co have been -7% over the past three years , -4% over the past five years , and -1% over the past ten years .